Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dennis Christensen

Showing results (1-10 of 143) with videos related to

Pageof 15
Sort By:
Human Vaccines & Immunotherapeutics|August 24, 2016
Vaccine adjuvants: Why and howDennis Christensen
Pharmaceutics|January 26, 2024
Head-to-Head Comparison of Novel Vaccine Technologies Comes with a Minefield of ChallengesDennis Christensen
Pain|December 1, 2000
Antinociceptive effect of systemic gabapentin in mononeuropathic rats, depends on stimulus characteristics and level of test integrationValérie Kayser, Dennis Christensen
Pain|November 9, 2000
The development of pain-related behaviour and opioid tolerance after neuropathy-inducing surgery and sham surgeryDennis Christensen, Valérie Kayser
Royal Society Open Science|March 28, 2024
Increased impact sensitivity in ageing high explosives; analysis of Amatol extracted from explosive remnants of warGeir P Novik, Dennis Christensen
Pain|October 31, 2002
The glycine/NMDA receptor antagonist (+)-HA966 enhances the peripheral effect of morphine in neuropathic ratsValéria Martinez, Dennis Christensen, Valérie Kayser
Pharmaceutics|December 23, 2020
Applying Microfluidics for the Production of the Cationic Liposome-Based Vaccine Adjuvant CAF09bSigne Tandrup Schmidt, Dennis Christensen, Yvonne Perrie
Seminars in Immunology|November 7, 2018
Immunocorrelates of CAF family adjuvantsGabriel Kristian Pedersen, Peter Andersen, Dennis Christensen
Drug Delivery and Translational Research|January 11, 2020
Translating the fabrication of protein-loaded poly(lactic-co-glycolic acid) nanoparticles from bench to scale-independent production using microfluidicsCarla B Roces, Dennis Christensen, Yvonne Perrie
Pain|November 24, 1999
Combined systemic administration of the glycine/NMDA receptor antagonist, (+)-HA966 and morphine attenuates pain-related behaviour in a rat model of trigeminal neuropathic painDennis Christensen, Michèle Gautron, Gisèle Guilbaud, et al.
Pageof 15

Showing results (1-10 of 143) with videos related to

Sort By:
Pageof 15
Human Vaccines & Immunotherapeutics|August 24, 2016
Vaccine adjuvants: Why and howDennis Christensen
Pharmaceutics|January 26, 2024
Head-to-Head Comparison of Novel Vaccine Technologies Comes with a Minefield of ChallengesDennis Christensen
Pain|December 1, 2000
Antinociceptive effect of systemic gabapentin in mononeuropathic rats, depends on stimulus characteristics and level of test integrationValérie Kayser, Dennis Christensen
Pain|November 9, 2000
The development of pain-related behaviour and opioid tolerance after neuropathy-inducing surgery and sham surgeryDennis Christensen, Valérie Kayser
Royal Society Open Science|March 28, 2024
Increased impact sensitivity in ageing high explosives; analysis of Amatol extracted from explosive remnants of warGeir P Novik, Dennis Christensen
Pain|October 31, 2002
The glycine/NMDA receptor antagonist (+)-HA966 enhances the peripheral effect of morphine in neuropathic ratsValéria Martinez, Dennis Christensen, Valérie Kayser
Pharmaceutics|December 23, 2020
Applying Microfluidics for the Production of the Cationic Liposome-Based Vaccine Adjuvant CAF09bSigne Tandrup Schmidt, Dennis Christensen, Yvonne Perrie
Seminars in Immunology|November 7, 2018
Immunocorrelates of CAF family adjuvantsGabriel Kristian Pedersen, Peter Andersen, Dennis Christensen
Drug Delivery and Translational Research|January 11, 2020
Translating the fabrication of protein-loaded poly(lactic-co-glycolic acid) nanoparticles from bench to scale-independent production using microfluidicsCarla B Roces, Dennis Christensen, Yvonne Perrie
Pain|November 24, 1999
Combined systemic administration of the glycine/NMDA receptor antagonist, (+)-HA966 and morphine attenuates pain-related behaviour in a rat model of trigeminal neuropathic painDennis Christensen, Michèle Gautron, Gisèle Guilbaud, et al.
Pageof 15